As the array of ETF product offerings has expanded in recent years, the biotech space has seen significant activity. Currently, there are five biotech ETFs that have accumulated nearly $3.5 billion... read more »
On Jim's Notes last week I discussed the issue of the leadership in the broad markets as a challenge. I am seeing money rotate into the defensive sectors over the last 3-4 weeks. If we looked at... read more »
